BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santos-Carvalho A, Álvaro AR, Martins J, Ambrósio AF, Cavadas C. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection. Prog Neurobiol 2014;112:70-9. [PMID: 24184719 DOI: 10.1016/j.pneurobio.2013.10.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Martins J, Elvas F, Brudzewsky D, Martins T, Kolomiets B, Tralhão P, Gøtzsche CR, Cavadas C, Castelo-Branco M, Woldbye DP, Picaud S, Santiago AR, Ambrósio AF. Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro. ASN Neuro 2015;7:1759091415598292. [PMID: 26311075 DOI: 10.1177/1759091415598292] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
2 Guerrera M, Abbate F, Di Caro G, Germanà G, Levanti M, Micale V, Montalbano G, Laurà R, Germanà A, Muglia U. Localization of cholecystokinin in the zebrafish retina from larval to adult stage. Annals of Anatomy - Anatomischer Anzeiger 2018;218:175-81. [DOI: 10.1016/j.aanat.2018.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Campos EJ, Martins J, Brudzewsky D, Correia S, Santiago AR, Woldbye DP, Ambrósio AF. Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina. Clin Exp Ophthalmol 2018;46:783-95. [PMID: 29442423 DOI: 10.1111/ceo.13176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Geloso MC, Corvino V, Di Maria V, Marchese E, Michetti F. Cellular targets for neuropeptide Y-mediated control of adult neurogenesis. Front Cell Neurosci 2015;9:85. [PMID: 25852477 DOI: 10.3389/fncel.2015.00085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
5 Sheng W, Yu M, Wang X, Jin M, Pang X, Li C, Zhang S, Li P, Wang X, Zhang C, Zhang Y, Liu K. Localization of neuropeptide receptor NPY4R in rat retina. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102246] [Reference Citation Analysis]
6 Reeber SL, Arancillo M, Sillitoe RV. Bergmann Glia are Patterned into Topographic Molecular Zones in the Developing and Adult Mouse Cerebellum. Cerebellum 2018;17:392-403. [PMID: 24906823 DOI: 10.1007/s12311-014-0571-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
7 Su Y, Foppen E, Fliers E, Kalsbeek A. Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats. Endocrinology 2016;157:3070-85. [PMID: 27267712 DOI: 10.1210/en.2016-1083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
8 Carniglia L, Ramírez D, Durand D, Saba J, Turati J, Caruso C, Scimonelli TN, Lasaga M. Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases. Mediators Inflamm 2017;2017:5048616. [PMID: 28154473 DOI: 10.1155/2017/5048616] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 18.4] [Reference Citation Analysis]
9 Cervia D, Catalani E, Casini G. Neuroprotective Peptides in Retinal Disease. J Clin Med 2019;8:E1146. [PMID: 31374938 DOI: 10.3390/jcm8081146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
10 Fonseca ICF, Castelo-Branco M, Cavadas C, Abrunhosa AJ. PET Imaging of the Neuropeptide Y System: A Systematic Review. Molecules 2022;27:3726. [PMID: 35744852 DOI: 10.3390/molecules27123726] [Reference Citation Analysis]
11 Pöstyéni E, Ganczer A, Kovács-Valasek A, Gabriel R. Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice. Front Pharmacol 2021;12:808315. [PMID: 35095518 DOI: 10.3389/fphar.2021.808315] [Reference Citation Analysis]
12 Cai W, Zhang K, Li P, Zhu L, Xu J, Yang B, Hu X, Lu Z, Chen J. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect. Ageing Res Rev 2017;34:77-87. [PMID: 27697546 DOI: 10.1016/j.arr.2016.09.006] [Cited by in Crossref: 120] [Cited by in F6Publishing: 106] [Article Influence: 24.0] [Reference Citation Analysis]
13 Christiansen AT, Kiilgaard JF, Klemp K, Woldbye DPD, Hannibal J. Localization, distribution, and connectivity of neuropeptide Y in the human and porcine retinas-A comparative study. J Comp Neurol 2018;526:1877-95. [DOI: 10.1002/cne.24455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Christiansen AT, Sørensen NB, Haanes KA, Blixt FW, la Cour M, Warfvinge K, Klemp K, Woldbye DPD, Kiilgaard JF. Neuropeptide Y treatment induces retinal vasoconstriction and causes functional and histological retinal damage in a porcine ischaemia model. Acta Ophthalmol 2018;96:812-20. [PMID: 30218483 DOI: 10.1111/aos.13806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sharif NA. iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants. J Ocul Pharmacol Ther 2018;34:7-39. [PMID: 29323613 DOI: 10.1089/jop.2017.0125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]